Nutriband (NTRB) Stock Price, News & Analysis

Company Overview

Nutriband Inc. (NASDAQ:NTRB) develops and manufactures transdermal patches and other wearable drug-delivery products for pharmaceutical, over-the-counter, consumer, and wellness markets. The company’s capabilities include product development, formulation, manufacturing, packaging, and private-label services for customers seeking patch-based delivery systems.

Nutriband’s portfolio includes consumer and wellness patches, as well as prescription-focused transdermal technologies. Its AVERSA platform is designed to incorporate abuse-deterrent features into transdermal products, with the goal of helping reduce the risk of drug extraction, misuse, or abuse. The company has also pursued applications for controlled-substance delivery, including an abuse-deterrent fentanyl patch in development.

The company serves customers in pharmaceutical, healthcare, and consumer-product markets and operates from the United States. Nutriband became publicly traded on the Nasdaq under the symbol NTRB in 2022. Its business combines contract and private-label manufacturing with the development of proprietary transdermal technologies and branded patch products.

Key Stats

• Today's Range: $7.23 to $7.65
• 50-Day Range: $2.81 to $8.99
• 52-Week Range: $2.80 to $9.19
• Volume: 19,426 shs
• Average Volume: 140,877 shs
• Market Capitalization: $90.84 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

Nutriband Stock Analysis - MarketRank™

Nutriband scored higher than 13% of companies evaluated by MarketBeat, and ranked 831st out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Reduce

Consensus Rating

Nutriband has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Nutriband has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Nutriband is -14.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nutriband is -14.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nutriband has a P/B Ratio of 13.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.06% of the float of Nutriband has been sold short.

Short Interest Ratio / Days to Cover

Nutriband has a short interest ratio ("days to cover") of 2.18, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nutriband has recently increased by 3.08%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nutriband does not currently pay a dividend.

Dividend Growth

Nutriband does not have a long track record of dividend growth.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: -0.10

News Sentiment

Nutriband has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Nutriband this week, compared to 1 article on an average week.

Search Interest

3 people have searched for NTRB on MarketBeat in the last 30 days.

MarketBeat Follows

4 people have added Nutriband to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nutriband insiders have not sold or bought any company stock.

Percentage Held by Insiders

52.21% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

19.70% of the stock of Nutriband is held by institutions.

Company Calendar

• Last Earnings: 9/04/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 12/07/2026
• Fiscal Year End: 1/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:NTRB
• CIK: 1676047
• Web: nutriband.com
• Phone: (407) 377-6695
• Fax: N/A
• Employees: 3
• Year Founded: 2016

Profitability

• EPS (Trailing Twelve Months): ($0.53)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$8.23 million
• Net Margins: -430.35%
• Pretax Margin: -430.41%
• Return on Equity: -109.07%
• Return on Assets: -95.54%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.21
• Quick Ratio: 4.02

Sales & Book Value

• Annual Sales: $2.04 million
• Price / Sales: 44.53
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.55 per share
• Price / Book: 13.58

Miscellaneous

• Outstanding Shares: 12,160,000
• Free Float: 5,809,000
• Market Cap: $90.84 million
• Optionable: Not Optionable
• Beta: 1.92